CX3CR1 and neoplasm: Finally, the harvested NCI-H630 tumors were measured and we found significant reduction in tumor weight in mice injected with CX3CR1-T cells, indicating effective anti-tumor activity of receptor positive T lymphocytes (Fig. 4d).